I read the Vyome has 8 million in annual revenue. The times-revenue multiplier for pharma looks to by 3x so a company value of 24 million. Depending on the OS the value would then lie at 9-12 cents per share...Vyome has raised 47.2 million $$. No telling how this will play out though